| | | Single nucleotide variant (5 prime UTR variant) | Neuromuscular disease, congenital, with uniform type 1 fiber +5 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Neuromuscular disease, congenital, with uniform type 1 fiber +5 more | |
| | | Single nucleotide variant (intron variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (intron variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +5 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +5 more | |
| | | Single nucleotide variant (nonsense) | Central core myopathy +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital multicore myopathy with external ophthalmoplegia +6 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (intron variant) | Central core myopathy +6 more | |
| | | Single nucleotide variant (intron variant) | King Denborough syndrome +6 more | |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (missense variant) | Neuromuscular disease, congenital, with uniform type 1 fiber +8 more | |
| | | Single nucleotide variant (missense variant) | Congenital multicore myopathy with external ophthalmoplegia +4 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +5 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital multicore myopathy with external ophthalmoplegia +8 more | |
| | | Single nucleotide variant (synonymous variant) | Congenital multicore myopathy with external ophthalmoplegia +8 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (synonymous variant) | RYR1-related myopathy | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +5 more | |
| | | Microsatellite (inframe_deletion) | Central core myopathy +5 more | |
| | | Single nucleotide variant (missense variant) | Congenital myopathy with fiber type disproportion +7 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +7 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +5 more | |
| | LOC129391106, RYR1 (M485V) | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | LOC129391106, RYR1 (R492C) | Single nucleotide variant (missense variant) | not provided +6 more | |
| | LOC129391106, RYR1 (R492H) | Single nucleotide variant (missense variant) | Malignant hyperthermia of anesthesia | |
| | | Single nucleotide variant (synonymous variant) | Congenital myopathy with fiber type disproportion +5 more | |
| | | Single nucleotide variant (synonymous variant) | not provided +6 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | LOC129391106, RYR1 (L521F) | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (intron variant) | not provided +8 more | |
| | | Single nucleotide variant (synonymous variant) | Central core myopathy +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (synonymous variant) | RYR1-related disorder +8 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | succinylcholine response - Toxicity +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +7 more | GPathogenic; drug response |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (synonymous variant) | Malignant hyperthermia, susceptibility to, 1 +10 more | |
| | | Single nucleotide variant (intron variant) | RYR1-related disorder +5 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (nonsense) | not provided +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Inborn genetic diseases +7 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +5 more | |
| | | Single nucleotide variant (missense variant) | not provided +8 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant) | Central core myopathy +8 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +8 more | |
| | | Single nucleotide variant (missense variant) | not provided +7 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +7 more | |
| | | Single nucleotide variant (missense variant) | Congenital multicore myopathy with external ophthalmoplegia +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | Congenital multicore myopathy with external ophthalmoplegia +6 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +5 more | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | |
| | | Single nucleotide variant (missense variant) | not provided +6 more | |
| | | Single nucleotide variant (missense variant) | RYR1-related disorder +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +7 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +5 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 +6 more | |
| | | Single nucleotide variant (missense variant) | Malignant hyperthermia, susceptibility to, 1 | |
| | | Single nucleotide variant (missense variant) | Central core myopathy +6 more | |